سعر نيمبكس 2 مجم/مل (10 مل = 20 مجم) 5 أمبولات 2022

Cisatracurium besylate 2 mg/mL solution for IV injection, 10 mL ampoule (20 mg), pack of 5 (GSK/Phoenix Egypt).

• Adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation in ICU.Population: Adults and pediatric patients as labeled (anesthesia setting)DailyMed / FDA

• Bradycardia, hypotension, flushing, bronchospasm, rash; rare severe anaphylaxis.International label, same formulation · DailyMed / FDA

• Known hypersensitivity to cisatracurium or other benzylisoquinolinium agents.International label, same formulation · DailyMed / FDA

• Causes paralysis of respiratory muscles — ventilation mandatory. Residual neuromuscular blockade; anaphylaxis; not for intramuscular use; caution in myasthenia gravis and other neuromuscular diseases; burns and electrolyte imbalance alter response.International label, same formulation · DailyMed / FDA

• US labels: no adequate studies in pregnant women; use only if clearly needed. Animal data incomplete for human risk assessment.International label, same formulation · DailyMed / FDA
• Unknown whether excreted in human milk; use caution.International label, same formulation · DailyMed / FDA

• Cisatracurium besylate: Competitive antagonist of acetylcholine at nicotinic receptors of the neuromuscular junction; intermediate-acting; Hofmann elimination and ester hydrolysis.